Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow

ABOUT CHI Advancing California Biomedical Research
and Innovation

CHI-California Healthcare Institute represents more than 275 leading biotechnology, diagnostics, medical device and pharmaceutical companies and public and private academic biomedical research organizations.

View Testimonials New CHI Board Members New CHI Members
CHI MEMBERS
MEMBER CENTER WHY JOIN CHI?

Join our statewide industry-academic coalition to get unparalleled access to policymakers, in-depth industry insight, and a network of the highest-level decision-makers.

Download Brochure
LEGISLATIVE ACTION GET INVOLVED

CHI’s Legislative Action Center provides information about state and federal legislation and regulations of importance to California’s life sciences community and the patients we serve.

Federal IssuesState Issues
INDUSTRY INTELLIGENCE GET THE SCOOP

Here you will find interactive and comprehensive tools to keep you up-to-date and educated on the issues that affect the biomedical industry.

Explore the Industry
BREAKING NEWS
Bayer Healthcare Wins FDA OK for Prostate Therapy Submitted on May 17, 2013

CHI member Bayer Healthcare recently announced that its has received approval from the U.S. Food and Drug Administration to begin marketing a new therapy for patients with prostate cancer. The new treatment, Xofigo, is the second prostate cancer therapy ever to be approved by the FDA. It is intended for patients with castration-resistant prostate cancer [...]

Washington Report – May 16, 2013 Vol. 9 No. 7 Submitted on May 16, 2013
St. Jude Medical Obtains Regulatory Approval for 3-D Imaging Technology Submitted on May 16, 2013
Genentech Obtains FDA Approval for Cancer Therapy, Test Submitted on May 15, 2013
Sacramento at a Glance – For the Week Ending May 17, 2013 Submitted on May 15, 2013
LATEST FROM THE CHI BLOG CHI Spotlight: CHI Recognizes Member Companies During 20th Anniversary

In honor of CHI’s 20th anniversary celebration, CHI President and CEO David L. Gollaher, Ph.D. will be recognizing member companies with commemorative plaques suitable for hanging or displaying at company headquarters. Michael Mussallem and David Gollaher On Feb. 19, CHI recognized Edwards Lifesciences’ leadership and dedication to improving California’s environment for biomedical innovation. Edwards Chairman and [...]

CHI TWITTER FEED

CHI's #BayerHealthCare recently announced that they have received FDA OK to sell prostate cancer treatment #Xofigo. http://t.co/8fpaxLWR9R


Follow CHI on twitter